Colitis ulcerative
RecruitingStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
- Disease:Colitis ulcerative
- Substances:–
Portugal- Participants:18–64 years · 65+ years
- Sponsor:Eli Lilly & Co.
Rare diseases
Investigational molecules
Locations
Back to Portugal49 clinical trials in Santa Maria Da Feira, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
PortugalThe busiest research cities in the country
What the registry says about research in the country
Ongoing research evaluating novel treatments for multiple sclerosis and epilepsy, with studies focusing on both relapsing and progressive forms of MS, as well as various types of seizure disorders.
Multiple trials testing new compounds like tolebrutinib and fenebrutinib for long-term disease management.
Studies focusing on preventing cardiovascular events and managing atherosclerotic disease, with particular attention to high-risk patients and post-stroke care.
Innovative therapies being tested to reduce major adverse cardiovascular events and improve patient outcomes.
Research targeting inflammatory bowel diseases, including studies on Crohn's Disease and ulcerative colitis, testing new therapeutic approaches.
Evaluating combination therapies and novel compounds for moderate to severe disease states.
Tell us about your condition – we search every trial in Europe and connect you with the right site.